CY1106086T1 - Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα - Google Patents

Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα

Info

Publication number
CY1106086T1
CY1106086T1 CY20061100500T CY061100500T CY1106086T1 CY 1106086 T1 CY1106086 T1 CY 1106086T1 CY 20061100500 T CY20061100500 T CY 20061100500T CY 061100500 T CY061100500 T CY 061100500T CY 1106086 T1 CY1106086 T1 CY 1106086T1
Authority
CY
Cyprus
Prior art keywords
methylon
androgens
beta
substituted
preparation
Prior art date
Application number
CY20061100500T
Other languages
Greek (el)
English (en)
Inventor
Dirk Leysen
Jaap Van Der Louw
Roberta Buma Bursi
Marcel Evert De Gooyer
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of CY1106086T1 publication Critical patent/CY1106086T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
CY20061100500T 1999-12-02 2006-04-10 Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα CY1106086T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204080 1999-12-02
PCT/EP2000/012009 WO2001040255A2 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens
EP00993259A EP1237904B1 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens

Publications (1)

Publication Number Publication Date
CY1106086T1 true CY1106086T1 (el) 2011-06-08

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100500T CY1106086T1 (el) 1999-12-02 2006-04-10 Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα

Country Status (27)

Country Link
US (1) US6706700B2 (cg-RX-API-DMAC7.html)
EP (1) EP1237904B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003515543A (cg-RX-API-DMAC7.html)
CN (1) CN1166680C (cg-RX-API-DMAC7.html)
AR (1) AR026655A1 (cg-RX-API-DMAC7.html)
AT (1) ATE317396T1 (cg-RX-API-DMAC7.html)
AU (1) AU778017B2 (cg-RX-API-DMAC7.html)
CA (1) CA2390226A1 (cg-RX-API-DMAC7.html)
CO (1) CO5251441A1 (cg-RX-API-DMAC7.html)
CY (1) CY1106086T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ301376B6 (cg-RX-API-DMAC7.html)
DE (1) DE60025958T2 (cg-RX-API-DMAC7.html)
DK (1) DK1237904T3 (cg-RX-API-DMAC7.html)
ES (1) ES2258037T3 (cg-RX-API-DMAC7.html)
HK (1) HK1047596B (cg-RX-API-DMAC7.html)
HU (1) HUP0203611A3 (cg-RX-API-DMAC7.html)
IL (1) IL149424A (cg-RX-API-DMAC7.html)
MX (1) MXPA02004939A (cg-RX-API-DMAC7.html)
NO (1) NO322422B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ518753A (cg-RX-API-DMAC7.html)
PE (1) PE20011033A1 (cg-RX-API-DMAC7.html)
PL (1) PL202999B1 (cg-RX-API-DMAC7.html)
RU (1) RU2242479C2 (cg-RX-API-DMAC7.html)
SK (1) SK287095B6 (cg-RX-API-DMAC7.html)
TW (1) TWI275593B (cg-RX-API-DMAC7.html)
WO (1) WO2001040255A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200203536B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059920A2 (en) * 1999-04-06 2000-10-12 Akzo Nobel N.V. Orally active 7.alpha.-alkyl androgens
PL208163B1 (pl) * 2002-01-21 2011-03-31 Organon Nv Sposób wytwarzania 7 α-metylosteroidów
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
EA024003B1 (ru) * 2011-10-07 2016-08-31 Эстетра С.П.Р.Л. Способ получения эстетрола
PT3310333T (pt) 2015-06-18 2020-06-08 Estetra Sprl Dose unitária orodispersível contendo um composto de estetrol
JP6866561B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロールを含有する口腔内崩壊錠
CA2988362C (en) 2015-06-18 2022-07-19 Mithra Pharmaceuticals S.A. Orodispersible tablet containing estetrol
TN2017000499A1 (en) 2015-06-18 2019-04-12 Mithra Pharmaceuticals S A Orodispersible dosage unit containing an estetrol component
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN111621141B (zh) * 2020-06-12 2022-04-08 广西大学 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (de) * 1995-10-10 1997-04-17 Jenapharm Gmbh Steroide mit einer 14, 15-Methylengruppe
DE19827522A1 (de) 1998-06-22 1999-12-23 Jenapharm Gmbh 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
CA2359218A1 (en) 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens

Also Published As

Publication number Publication date
ZA200203536B (en) 2003-08-04
AU778017B2 (en) 2004-11-11
SK287095B6 (sk) 2009-12-07
PL355689A1 (en) 2004-05-17
CZ301376B6 (cs) 2010-02-03
AR026655A1 (es) 2003-02-19
DE60025958D1 (de) 2006-04-20
NO20022564L (no) 2002-05-30
US6706700B2 (en) 2004-03-16
NO20022564D0 (no) 2002-05-30
RU2242479C2 (ru) 2004-12-20
ATE317396T1 (de) 2006-02-15
HUP0203611A3 (en) 2004-07-28
CN1402735A (zh) 2003-03-12
DE60025958T2 (de) 2006-07-27
DK1237904T3 (da) 2006-06-06
EP1237904B1 (en) 2006-02-08
NZ518753A (en) 2004-05-28
MXPA02004939A (es) 2003-05-23
HK1047596B (en) 2006-04-21
TWI275593B (en) 2007-03-11
HK1047596A1 (en) 2003-02-28
US20030100543A1 (en) 2003-05-29
CZ20021894A3 (cs) 2002-08-14
IL149424A0 (en) 2002-11-10
SK7582002A3 (en) 2002-09-10
WO2001040255A2 (en) 2001-06-07
AU2838301A (en) 2001-06-12
IL149424A (en) 2007-05-15
EP1237904A2 (en) 2002-09-11
CO5251441A1 (es) 2003-02-28
JP2003515543A (ja) 2003-05-07
CN1166680C (zh) 2004-09-15
ES2258037T3 (es) 2006-08-16
CA2390226A1 (en) 2001-06-07
WO2001040255A3 (en) 2001-11-15
HUP0203611A2 (hu) 2003-03-28
PL202999B1 (pl) 2009-08-31
NO322422B1 (no) 2006-10-02
PE20011033A1 (es) 2001-10-11

Similar Documents

Publication Publication Date Title
CY1106086T1 (el) Υποκαθισταμενα 14,15-βητα-μεθυλικα ανδρογονα
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
CY1109404T1 (el) Μεθοδος δια την παρασκευη προϊοντων στεροειδους ορμονης. η οποια περιλαμβανει παραγοντα σταθεροποιησεως εις μη-κρυσταλλικην μορφη
ZA200107631B (en) Indoline derivatives as progesterone antagonists.
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
AP1414A (en) Controlled release galantamine composition.
MXPA03000065A (es) Composiciones de micelas polimericas.
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
ECSP083351A (es) Composiciones farmacéuticas
TR199800648A1 (xx) �ki veya daha fazla etken madde i�in ila� verme sistemi.
CY1105065T1 (el) Φαρμακευτικα μεσα βασιζομενα σε γεσταγονα για δepματικη χρηση
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
MY111841A (en) Injectable liposomal pharmaceutical preparations
NO965516L (no) Sterolderivater anvendt til regulering av meiose
ATE212351T1 (de) Androsten-derivate
FI20011703A7 (fi) Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä
CY1115064T1 (el) Διαδερμικο συστημα παραδοσης ορμονων χωρις ενισχυτες διεισδυσης
ATE452641T1 (de) Orale pharmazeutische zusammensetzung enthaltend 15-hydroxytestosteron und seine derivate
IL139861A (en) 17beta-AMINO-AND HYDROXYLAMINO -11 beta - ARYLSTEROID DERIVATIVES, METHODS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MXPA01011606A (es) Terapia anti-inflamatoria para infeccion mediada por inflamacion.
ATE225800T1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
DK0825865T3 (da) Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
CY1105168T1 (el) Διφασικη συνθεση με τραμαδολη
BG104424A (en) Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride